Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. September 2024 18:48 ET | Quelle: Robbins LLP

Moderna, Inc. REMINDER – MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline

Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine
28. August 2024 15:04 ET | Quelle: Robbins LLP

Shareholder Rights Law Firm Robbins LLP Urges Moderna, Inc. Stockholders to Seek Counsel for the MRNA Class Action

Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine
20. August 2024 20:08 ET | Quelle: Robbins LLP

MNRA STOCK NEWS: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Moderna, Inc. Class Action

Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine
14. August 2024 13:11 ET | Quelle: Robbins LLP

Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA

Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine
27. Mai 2020 14:25 ET | Quelle: Portnoy Law

Moderna, Inc. Investors: Company Investigated by the Portnoy Law Firm

LOS ANGELES, May 27, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Moderna, Inc. ("Moderna") (NASDAQ: MRNA) investors that the firm has initiated an investigation into possible securities...